Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc.

OTC:OTLC

Overview | Financials
Company Name Oncotelic Therapeutics, Inc.
Symbol OTLC
Currency USD
Price 0.037
Market Cap 14,731,883
Dividend Yield 0%
52-week-range 0.01 - 0.09
Industry Biotechnology
Sector Healthcare
CEO Dr. Vuong Trieu Ph.D.
Website https://www.oncotelic.com

An error occurred while fetching data.

About Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of

Related Stocks

Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc.

VICP

2 USD

Medicine Man Technologies, Inc. logo

Medicine Man Technologies, Inc.

SHWZ

0.61 USD

Allied Corp. logo

Allied Corp.

ALID

0.101 USD

Financials

Numbers are in millions USD

Numbers are in millions USD